Immunology and Hematology CVT Flashcards
What is the MOA of cyclophosphamide?
o Alkylation of DNA during the S phase in cell cycle → Can be lethal to cell or produce miscoding errors (inhibit cell replication or DNA transcription)
§ Produces T- and B-cell lymphopenia
§ Suppresses both T-cell activity and antibody production
What are the indications for cyclophosphamide in dogs and cats?
· Indications in Dogs: Corticosteroid-resistant IMHA or IMTP, Rheumatoid arthritis; Polymyositis (in conjunction with corticosteroids)
· Indications in Cats: IMHA; Rheumatoid arthritis
What are the side effects of cyclophosphamide?
Myelosuppression; Gastroenteritis; Alopecia; Hemorrhagic cystitis
What is the MOA of azathioprine?
o Purine analog that is metabolized to ribonucleotide monophosphates → Poor conversion to diphosphates and triphosphates → ↑intracellular monophosphates → feedback inhibition of the enzymes required for biosynthesis of purine nucleotides
§ Triphosphate analogs formed → incorporated into DNA → ribonucleic acid miscoding and faulty transcription
§ Greater effect on humoral immunity
What are the indications of azathioprine in dogs?
Indications in Dogs: IMHA (administered in conjunction with steroids and/or cyclophosphamide); IMTP; Autoimmune skin disease; Chronic Hepatitis; Myasthenia Gravis; IM Glomerulopathy; Chronic Atrophic Gastritis; SLE; Inflammatory Bowel Disease
What are the indications of azathioprine in cats?
**VERY Myelotoxic in cats**
What are side effects of azathioprine?
Bone Marrow Suppression: Leukopenia, anemia, thrombocytopenia; Acute pancreatitis; Hepatotoxicity
What is the MOA of methotrexate?
o Competitively inhibits folic acid reductase (necessary for reduction of dihydrofolate →tetrahydrofolate) → affects production of purines and pyrimidines
§ Manifest during S phase (cell cycle)
What are the indications or methotrexate in dogs and cats?
Antineoplastic in lymphoma, carcinomas, sarcomas
What is the major side effect of methotrexate?
Gastrointestinal toxicity
How do glucocorticoids work?
o Glucocorticoids stabilize cell membrane of endothelial cells
o Inhibits:
§ Production of local chemotactic factors (¯ infiltration neutrophils, monocytes, and lymphocytes)
§ Secretion of destructive proteolytic enzymes (collagenase, elastase, and plasminogen activator; in allogeneic tissue)
§ Release of arachidonic acid from membrane phospholipids → prevents synthesis of prostaglandins, thromboxanes, and leukotrienes (major mediators of inflammation)
o Redistribute monocytes and lymphocytes from peripheral circulation to lymphatics/bone marrow (affects primarily T cells)
o Decrease T-cell activation and cytotoxicity
o Decrease Cytokine activity
o Alter macrophage function
What is the MOA of cyclosporine?
· Bound in cytosol (lymphocytes) by cyclophilins (cyclosporine-binding proteins)
o Cyclosporine-cyclophilin complexes → calcium-dependent calcineurin-calmodulin complexes → impede calcium-dependent signal transduction
§ Transcription factors → promote cytokine gene activation are direct or indirect substrates of the serine-threonine phosphatase activity of calcineurin
§ Enzymatic activity ¯ by association of cyclosporine-cyclophilin bimolecular complex with calcineurin
§ Inhibits early T-cell activation (G0 phase of the cell cycle)
§ Prevents synthesis of several cytokines (IL-2)
§ Without IL-2 → further T-cell proliferation is inhibited (T-cell cytotoxic activity ¯)
§ Stimulates cells to secrete transforming growth factor–β (TGF-β) protein → potent inhibitor of IL-2–stimulated T-cell proliferation and generation of antigen-specific cytotoxic lymphocyte
o NOT cytotoxic or myelotoxic
Which immunosupressant is specific for lymphocytes?
Cyclopsorine (specificity spares other rapidly dividing cells; allows nonspecific host defense to continue to function)
What is a potential reverse effect of cyclosporine in cats?
Can be nephrotoxic
What is the MOA of tacrolimus?
Binds in cytosol (lymphocytes) with an immunophilin, FK-binding protein (FKBP) → tacrolimus-FKBP complex binds to calcineurin and inhibits its phosphatase activity→ directly and indirectly inhibits de novo expression of nuclear regulatory proteins and T-cell activation genes o Transcription of cytokines (IL-2, IL-3, IL-4, IL-5, interferon-γ, TNF-α, and granulocyte-macrophage colony-stimulating factor) responsible for lymphocyte activation is suppressed
o ¯ IL-2 and IL-7 receptors
o Inhibits B-cell proliferation/production of antibody (unknown mechanism)
What are the indications of tacrolimus in vet med?
o Topically: 0.1% solution, controlled discoid lupus erythematosus and pemphigus foliaceus in dogs (Rosenkrantz et al., 2004)
o Topical 0.02% aqueous suspension for the effective treatment of dogs with KCS (Berdoulay, English, and Nadelstein, 2005)
What is the MOA of sirolimus?
· Macrocyclic antibiotic with a structure similar to tacrolimus → binds in cell cytosol to FKBP
o Affect different and distinct sites in the signal transduction pathway
o Immunosuppressive → sirolimus-FKBP complex blocking activation of target of rapamycin, (mTOR)
§ mTOR is serine/threonine protein kinase →regulation of cell proliferation through the initiation of gene translation in response to AA, growth factors, cytokines, and mitogens
§ Kinase activity of cyclin-dependent kinase-2 and cyclin-dependent kinase-4 (cell cycle regulators) also inhibited
§ Blocks IL-2 and other growth factor–mediated signal transduction (signal 3 of the allograft rejection response) and the calcium-independent CD28/B7 (CD80/CD86) costimulatory pathway
□ Cyclosporine and tacrolimus block T-cell cell cycle progression at the GO to G1 stage
□ Sirolimus prevents cells from progressing from G1 to the S phase
® Blocks T-cell activation by IL-2, IL-4, and IL-6 and stimulation of B-cell proliferation by lipopolysaccharide
® Directly inhibits B-cell immunoglobulin synthesis caused by interleukins
What are potential side effects of sirolimus?
hyperlipidemia, thrombocytopenia, delayed wound healing, delayed graft function, mouth ulcers, pneumonitis, and interstitial lung disease
What is the MOA of mycophenolate?
o Prodrug hydrolyzed by liver esterases → mycophenolic acid
o MOA:
§ Cytostatic for lymphocytes → inhibition of inosine monophosphate dehydrogenase → enzyme necessary for de novo purine biosynthesis
o Relatively selective inhibitor of T- and B-cell proliferation during the S phase of the cell cycle via its ability to prevent guanosine and deoxyguanosine biosynthesis
What is the MOA of leflunomide?
· Synthetic organic isoxazole → intestinal mucosa metabolizes to active form = A77 1726
· Part of its antiproliferative activity during the S phase (cell cycle) → inhibiting de novo pathway of pyrimidine biosynthesis
o Target: enzyme dihydroorotate dehydrogenase
What is a potential side effect of leflunomide in dogs?
o GI toxicity (dogs) → accumulation of metabolite trimethylfluoroanaline (TMFA)
§ Cats: TMFA does not present the toxicity problem encountered
What is FTY 720?
from myriocin (fungus-derived sphingosine analog) o After phosphorylation, FTY 720 engages lymphocyte sphingosine-1-phosphate receptors and profoundly alters lymphocyte trafficking → acting as a functional sphingosine-1-phosphate antagonist o Sequesters naïve and activated CD4+ and CD8+ T and B cells from the blood into lymph nodes and Peyer's patches (without affecting function) o Does not impair cellular or humoral immunity to systemic viral infection nor does it affect T-cell activation, expansion/proliferation, or immunologic memory o Synergizes effectively with inhibitors of T-cell activation and proliferation to prevent allograft rejection
Is there alloantibody production in dogs?
NO! · No clinically important alloantibodies (isoantibodies) present before sensitization with a transfusion
· Pregnancy does not cause sensitization because of a complete placenta in dogs → NO alloantibody production
What is the most antigenic blood type in dogs?
DEA 1.1
Anti-DEA 1.1 antibodies will develop after 4 days